Prevention of progression of nephropathy

Nephrology Dialysis Transplantation

Volumn 12, Issue SUPPL. 2, 1997, Pages 63-66

  Klahr, Saulo ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Blood pressure; Dietary therapy; GFR; Proteinuria; Randomized clinical trials; Renal disease

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRANSFERRIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; LIPOPROTEIN BLOOD LEVEL; MEAN ARTERIAL PRESSURE; NEGRO; PRIORITY JOURNAL; PROTEINURIA; TRANSFERRIN BLOOD LEVEL;

DIETARY PROTEINS; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY DISEASES; PROTEINURIA; RANDOMIZED CONTROLLED TRIALS;

EID: 0030747253     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988; 318: 1657-1666
2. Peterson JC, Adler S, Burkart JM et al. Blood pressure control, proteinuria and the progression of renal disease; the Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123: 754-762
3. Cameron JS, Turner DR, Ogg CS, Chandler C, Williams DG. The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 1978; 10: 213-218
4. Cameron JS, Turner DR, Heaton J et al. Idiopathic mesangiocapillary glomerulonephritis: comparison of types I and II in children and adults and long-term prognosis. Am J Med 1983; 74: 175-192
5. Erwin DR, Donadio DSV, Holley KE. The clinical course of idiopathic membranous nephropathy. Mayo Clin Proc 1973; 48: 697-712
6. D'Amico G, Minetti L, Ponticelli C et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 1986; 228: 363-378
7. Klahr S, Levey AS, Beck GJ et al., for the Modification of Diet in Renal Disease Study. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330: 877-884
8. Praga M, Hernandez E, Montoyo C, Andres A, Ruilope LM, Rodicio JL. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 1994; 20: 240-248
9. Maschio G, Alberti D, Janin G et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334: 939-945, 1996
10. Parving HH, Andersen AR, Hommel E, Smidt U. Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension 1985; 7: 114-117
11. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta regressive analysis. Ann Intern Med 1993; 118: 129-138
12. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-183
13. Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J (Clin Res) 1982; 285: 685-688
14. Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br J Med 1986; 293: 471-474
15. Marre M, Leblanc H, Suarez L, Guyenne TT, Menard J, Passa P. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J (Clin Res) 1987; 294: 1448-1452
16. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329: 1456-1462
17. Klag MJ, Whelton PK, Randall BL et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18
18. Hunsicker LG. Studies of therapy of progressive renal failure in humans. Semin Nephrol 1989; 9: 380-394
19. Fukui M, Nakamura T, Ebihara I, Nagaoka I, Tomino Y, Koide H. Low-protein diet attenuates gene expression of platelet derived growth factor and transforming growth factor β in experimental glomerulosclerosis. J Lab Clin Med 1993; 121: 224-234
20. Nakamura T, Fukui M, Ebihara I, Tomino Y, Koide H. Low protein diet blunts the rise in glomerular gene expression in focal glomerulosclerosis. Kidney Int 1994; 45: 1593-1605
21. Eddy A. Protein restriction reduces transforming growth factor β and interstitial fibrosis in chronic purine aminonucleoside nephrosis. Am J Physiol 1994; 286: F884-F893
22. Ihle BU, Becker GJ, Whitworth JA, Charlwood RA, Kincaid Smith PS. The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 1989; 321: 1773 1777
23. Walker JP, Dodds RA, Murrells TJ, et al. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 1989; 2: 1411-1415
24. Levey AS, Adler S, Caggiula AW, et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis 1996; 27: 652-663